Ceriporia lacerata Mycelium Culture Medium as a Novel Anti-Aging Microbial Material for Cosmeceutical Application

Abstract

Skincare is very critical in preventing aging and skin trouble, which is difficult to recover if progressed. However, the development of effective anti-aging solutions is still on the horizon. The purpose of this study was to evaluate the functional efficacy of Ceriporia lacerata exo-pharmaceutical substance (CLEPS) in view of its use in innovative skin care cosmetics. CLEPS was found to have no cytotoxicity against normal human dermal fibroblasts and B16 melanoma cells in a wide concentration range of 0.05–7 mg/mL. It exhibited a whitening effect by inhibiting melanin synthesis comparable to that of the respective reference compound (arbutin). Notably, CLEPS not only substantially increased collagen (65.4%) and filaggrin synthesis (36%), but also significantly inhibited the activity of collagenase (93.4%), suggesting that CLEPS could prevent skin barrier damage or skin wrinkles. In addition, it showed an excellent anti-inflammatory effect and wound-healing effect. Overall, CLEPS exhibited exceptional anti-aging effects in human skin cells, designating as a potential natural cosmeceutical ingredient.

1. Introduction

Among other organs, human skin is a vanguard interface constantly exposed to harmful external stimuli, such as general metabolic reactions, cosmetics, and ultraviolet (UV) irradiation. These factors lead to undesired biochemical byproducts, including reactive oxygen species (ROS), matrix metalloproteinases (MMPs), and advanced glycation end-products (AGEs), which can trigger skin aging, including wrinkles, pigmentation, and loss of skin tone [1,2]. ROS, dangerous oxygen molecules as a pleiotropic physiological signal transmitter, mainly induce cross-linking of collagen and elastin to induce wrinkles and lower skin recovery, which are considered to be the main driving force of aging caused by UV rays and pollution [3]. MMPs are enzymes activated by UV exposure or inflammation, which contribute to collagen breakdown while inhibiting the formation of new collagen [1]. The formation of AGEs is the result of the reaction of glucose with proteins, including skin collagen, which can contribute to loss of elasticity, wrinkles, inflammation, inhibition of skin cell growth, and accelerated aging [2].

Since oxidative stress is one of the metabolic factors and pathways most associated with cellular aging, the consumption of functional foods and functional cosmetics with antioxidant activity is increasing significantly. Therefore, antioxidants can be beneficial to the human body by directly or indirectly neutralizing ROS, via regulating metabolic pathways and gene expression as the main cellular activation mechanisms.

Natural metabolites derived from microbial sources have been used in a variety of applications as a nutritional source and as a skin care agent [4]. Among them, the metabolites derived from fungi contain biologically active ingredients of considerable commercial value, including oligosaccharides, exopolysaccharides (EPS), enzymes, peptides, vitamins, and biosurfactants. These metabolites are widely used as main raw materials for pharmaceuticals, functional foods, and cosmetic products [5,6,7,8,9]. Packed with thousands of antioxidants and anti-inflammatory properties, they have been widely used to fight aging by improving the skin’s natural defenses, restoring skin elasticity, increasing moisture content, promoting collagen synthesis, and exhibiting skin-whitening effects [4,5]. Besides, these compounds, replacing traditional chemical ingredients, are applied in a variety of cosmetic products used to improve the health and beauty of mankind in a biosafe and detoxifying manner. In particular, the unique biocompatibility, non-toxicity, and functionality of fungal EPS have been widely employed in the cosmetic industry [4]. For instance, metabolic compounds such as Schizophyllan, a polysaccharide of β-1,3 β-glucan with β-1,6 branching, extracted from Schizophyllum commune, are known to help with skin anti-inflammatory and UV protection effects [10]. Galactomyces ferment filtrate (GFF) has been isolated from Galactomyces candidum to study cosmeceutical effects on reduction of facial skin pores, skin pigmentation, and relieve oxidative stress, while the mechanisms of action underlying EPS of GFF along with its compound information are still unidentified [11]. Ceriporia lacerata is a type of white putrefactive filamentous fungus that plays an important role in bioremediation by breaking down cellulose and lignin [12,13]. The bioactive efficacy of C. lacerata mycelium (CLM) culture has been studied to control hyperglycemia levels [14], insulin secretion through cytoprotective effects [15], and insulin signaling through activation of AMP-activated protein kinase (AMPK) and glucose transporter type 4 (GLUT4) [16,17]. However, the pharmacological effect of CLM on anti-oxidation and anti-aging is not yet known.

The cultured C. lacerata is composed of microscopic polypores; thus, it looks like white moss (Figure 1a). During the liquid culture process, various secondary metabolites, e.g., exo-metabolites, are generated depending on the environmental conditions (Figure 1b). However, there are no reports of C. lacerata or CLM on skin care-associated effect. Therefore, this study aimed to investigate the antioxidant, wound healing, wrinkle improvement, moisturizing, and whitening effects of CLM on the anti-aging mechanism of skin cells. To the best of our knowledge, this study is the first report to propose a new route for skincare at the cellular level based on the anti-aging mechanism using anti-diabetic ingredients derived from the culture of CLM, an emerging microorganism [14,15,16,17].

2. Materials and Methods

2.1. Ceriporia Lacerata Exo-Pharmaceutical Substance Preparation

The strain used in this experiment was used by inoculating CLM (FugenCellTech, Sangju, Korea) on potato dextrose agar (PDA, Difco. Co., Sparks, MD, USA) medium and culturing at 25 °C for 9 days. The culture broth of C. lacerata mycelium was pre-cultured in a potato dextrose broth for 10 days. After pre-culturing is completed, the mycelium culture medium was mixed with glucose (12.5 g/L), potato starch (2.5 g/L), defatted soybean (5 g/L), and glycerin esters of fatty acids from plant oil (0.12 g/L) as an anti-foaming agent, following by additional incubation for 11 days at 23 °C. By taking a centrifugation to separate the precipitates, the clear supernatant of the culture medium of CLM was ultrafiltered with an ultrafiltration technique utilizing a polysulfone membrane with 3.6~8.0 m² (molecular weight cut off: 30~100 kDa). The stock solution (100%) of CLEPS was dissolved in the culture solution and used for all the biological analyses in this work, without adding any solvents, co-solvents, reagents, or chemicals, which confirms biosafe and high-quality green cosmetic ingredients.

2.2. Measurement of Antioxidant Activity

2.2.1. 2,2-Diphenyl-1-picryl-hydrazyl-hydrate (DPPH) Scavenging Activity Assay

Free radical scavenging ability of the CLEPS was tested by DPPH radical scavenging photometric assay according to methodology described by Choi et al. [18] and Kedare et al. [19]. The CLEPS was mixed with 90 mM methanolic DPPH to form final solution concentrations of 0.5, 1, and 5 mg/mL in 96-well plates, which were incubated for 30 min at 25 °C and the absorbance (OD) was read in a microplate reader (Multiskan GO, Thermofisher Scientific, Waltham, MA, USA) at a wavelength of 517 nm. Three independent experiments were performed. Ascorbic acid (AA, 1 mg/mL) was used as the positive control. DPPH inhibitory percent was calculated by following the formula below:

DPPH scavenging % = [control A0 − sample A1/control A0] × 100, where A1 indicates the absorbance of sample, while A0 indicates the absorbance of control (methanolic solution of DPPH).

2.2.2. 2,2-Azinobis-(3-ethylbenzothiazoline-sulfonic acid) (ABTS) Radical Scavenging Activity

Determination of the free radical scavenging activity of CLEPS solutions was achieved by ABTS radical cation decolorization assay according to a methodology described by Kedare et al. [19]. ABTS cation radical generation was accomplished by combining 10 mg of ABTS and 2 mg of potassium persulfate in water. The solution was placed in the dark at 25 °C for about 12 h before use. ABTS solution (1 mL) was diluted with 60 mL of methanol, then the CLEPS was mixed with 90 µM methanolic ABTS to form final solution concentrations of 0.5, 1, and 5 mg/mL in 96-well plates. The plates were incubated at 25 °C for 30 min and the OD was measured at a wavelength of 734 nm using a Multiskan GO instrument. Three independent experiments were performed. Ascorbic acid (AA, 1 mg/mL) was used as the positive control. ABTS inhibitory percent was calculated by following the formula below:

ABTS scavenging % = [control A0 − sample A1/control A0] × 100 where A1 indicates the absorbance of sample, while A0 indicates the absorbance of control (methanolic solution of ABTS).

2.3. Cell Viability Assay

To evaluate cell viability of CLEPS on the skin cells, the human dermal fibroblasts (NHDF) (ATCC) were cultured in DMEM (high glucose) (WelGENE, KR) supplemented with 10% fetal bovine serum (FBS) (WelGENE, Gyeongsan, Korea) and 1% penicillin/streptomycin (WelGENE, Gyeongsan, Korea) at 37 °C in a 5% CO₂ incubator (UP50H, Forma Scientific, Marietta, OH, USA). The cells were incubated at 7 × 10⁴ cells/well in a 12 well plate. After confirming the cell adhesion, it was transferred to a serum-free media and the solutions were treated at a working concentration in each well for 72 h. The thiazolyl blue tetrazolium bromide (MTT) (Sigma, St. Louis, MO, USA) solution at a concentration of 100 μg/mL was added to each well and incubated at 37 °C, 5% CO₂ for 2 h. Then, all the culture medium was removed and 500 μL of DMSO (Duchefa Biochemicals, Haarlem, The Netherlands) was added to each well. The absorbance at 570 nm was measured with an ELISA reader (Epoch, Bio-tek INC, Winooski, VT, USA). The cell culture medium was used as a negative control (control (-)).

2.4. Expression Level of Filaggrin

To showcase how CLEPS influences the skin barrier function, the mRNA expression level of filaggrin was measured by a RT-PCR. HaCaT cell was cultured at 2 × 10⁴ cells/well in a 24-well plate using DMEM medium containing 10% FBS, 1% penicillin, and 1% streptomycin, and then cultured at 37 °C, 5% CO₂ incubator for 24 h. After removal of the supernatant, each sample was added in DMEM medium excluding FBS for 24 h at 37 °C, 5% CO₂ incubator. After incubation, the supernatant was removed and the RNA harvested according to the manual using Easy Blue lysis reagent (iNtRON Biotechnology, Seongnam, Korea). RT PreMix (BIONEER, Daejeon, Korea) was used at 42 °C for 60 min and 95 °C for 5 min to synthesize cDNA. The PCR primers (Macrogen, Daejeon, Korea) were designed as presented in

Table 1. RT-PCR primers used in the filaggrin assay.

Genes	Sequences	Accession No.	Amplicon Size, bp
β-actin (Human)	Forward 5’-GTCACCAACTGGGACGACATG-3 Reverse 5’-GCCGTCAGGCAGCTCGTAGC-3’	NC_000019	640
Filaggrin (Human)	Forward 5’-TGATGCAGTCTCCCTCTGTG-3 Reverse 5’-TGTTTCTCTTGGGCTCTTGG-3’	NC_000001	610

and Western blotting was performed to determine the amount of filaggrin expression.

To measure the protein level of filaggrin, each cell was aliquoted in a 6-well plate at 1 × 10⁵ cells/well using DMEM medium containing 10% FBS, 1% penicillin, and 1% streptomycin, followed by 24 h incubation. After the supernatant solution was removed and refilled with fresh medium, the cells were further cultured for 24 h. The plate from which the supernatant was removed was treated with Protein Solution (iNtRON Biotechnology, Seongnam, Korea) to lyse the cells, and then centrifuged (13,000 rpm, 15 min, 4 °C). Then, to measure the protein concentration in the supernatant, it was mixed with 30 µg NuPAGE LDS sample buffer (Novex, CA) and boiled at 100 °C for 5 min. Subsequently, the protein was transferred to transfer membranes (Millipore, Burlington, MA, USA) after SDS-PAGE using Mini PROTEAN^® Tetra cells (552BR, Bio-Rad, Hercules, CA, USA). Non-specific protein binding portions were blocked by reacting with Tris-buffered saline with 0.1% Tween^® 20 (TBST) and 5% skim milk for 1 h. The primary antibody (filaggrin: Santa Cruz Biotechnology, Dallas, TX, USA) was diluted to 1:1000 (v/v), stirred overnight at 4 °C, and washed 3 times with TBST for 15 min. Then, the secondary antibody solution was added, following by stirring at 25 °C for 1 h and washing 3 times with TBST for 15 min, and then Immobilon western Chemiluminescent HRP Substrate (MerckMillipore, Darmstadt, Germany) was used to blot the bands, which were imaged with Omega Lum G (Aplegen, Pleasanton, CA, USA). As an internal standard protein, β-actin (Sigma, St. Louis, MO, USA) was used.

2.5. Melanogenesis Inhibition Test of B16 Melanoma Cells

To find safe doses for melanin inhibition assay and observe the inhibition activity of melanin by the CLEPS sample treatment, B16 melanoma cells (ATCC) at 1 × 10⁵ cells/well were cultured in a 6-well culture plate containing DMEM medium with 10% FBS and 1% penicillin-streptomycin added at 37 °C and 5% CO₂ condition. A melanin synthesis inducer, α-melanocyte stimulating hormone (α-MSH), was prepared by dissolving it in 10% DMSO at a concentration of 50 μM. After incubating for 24 h, the CLEPS solutions were added and immediately treated with α-MSH (50 nM), following by additional incubation for 72 h. Next, the cell plates were washed twice with PBS and trypsinized, and then the recovered cells were centrifuged at 5000 rpm for 10 min to remove the supernatant, after which a cell pellet was obtained. The intracellular melanin content was determined according to the method previously reported with minor modification [20]: melanin was harvested by dissolving it in 2 N NaOH containing 10% DMSO at 60 °C for 4 h, which was transferred to a 96-well plate. DMSO (0.1% v/v) was the solvent for the control and the test samples with α-MSH. The absorbance was measured at 475 nm with an ELISA reader.

2.6. Anti-Inflammation Assay of Nitric Oxide (NO)

To examine the NO production, RAW 264.7 cells (ATCC) were cultured and inoculated at a density of 1 × 10⁴ cells/well in a 96-well plate. The cells were exposed to CLEPS (100 or 500 µg/mL) for 1 h, followed by stimulation of the cells with lipopolysaccharide (LPS) (1 µg/mL). 10 µg/mL of α-lipoic acid (LA) (Sigma) was used as a positive control. After 24 h, the amount of NO in the cell medium was measured in a volume of 100 µL consisting of a 1:1 ratio mixture of solution A (1% 4-aminobenzenesulfonamide, 0.2% N1-(naphthalen-1-yl) ethane-1,2-diamine dihydrochloride) and solution B (5% phosphoric acid), which was added with an equal volume of medium. After 15 min, the absorbance measurements were performed at 550 nm using a microplate reader (Multiskan GO instrument). The culture medium without LPS (normal group) was used as the negative control.

2.7. Anti-Inflammation Assay of Inducible Nitric Oxide Synthase (iNOS), Cyclooxygenase-2 (COX2), and Tumor Necrosis Factor α (TNF α)

The RAW 264.7 cells (5 × 10⁴ cells/well) on 6 cm dishes were cultured overnight, which were pretreated for 1 h with CLEPS. The cells were exposed to LPS (1 µg/mL) and incubated for 24 h. 10 µg/mL of α-lipoic acid (LA) (Sigma) was used as a positive control. After obtained the proteins using a lysis buffer (Cell Signaling Technologies, Danvers, MA, USA), it was mixed with a phosphatase inhibitor cocktail and protease (Thermo Fisher Scientific, Inc., Waltham, MA, USA), after which the whole lysates were measured using a detergent-compatible protein assay (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The proteins were separated by SDS-PAGE gel electrophoresis. The transferred membranes (Immobilon^®-P, Millipore, Burlington, MA, USA) were blocked in TBST buffer (Sigma, St. Louis, MO, USA), which included 5% skim milk, and the membranes were kept at 4 °C with antibodies against iNOS, COX2, or TNFα (1:1000). The culture medium without LPS (normal group) was used as the negative control.

2.8. Synthesis of Collagen and Inhibition of Collagenase

The NHDF cells were cultured and pretreated with CLEPS to examine the efficacy of CLEPS on collagen formation and collagenase inhibition by taking a procollagen type I C-peptide EIA kit (Takara, Kusatsu, Japan) and a human pro-MMP-1 Quantikine ELISA kit (R&D system, Minneapolis, MN, USA), respectively. As a method of measuring the activity level of collagenase, an enzyme that decomposes collagen, an antibody against collagenase (MMP-1) was used, while Phorbol 12-myristate 13-acetate (PMA) (Sigma) was used to activate the expression of MMP-1. 10 ng/mL of TGF-β (Sigma) was dissolved in culture medium was used as a positive control, while the culture medium was the negative control.

2.9. In Vitro Wound Healing Assay

To examine the effect of CLEPS on wound healing, HaCaT cells (1 × 10⁴ cells/well) were plated into 12-well plates for 48 h and grew to ~100% confluence. The monolayer was wounded using the tip of a sterile 200 μL pipette. Cell debris was removed by washing twice with PBS. These cells were then replaced with fresh 1% serum medium with or without CLEPS (100, 500 and 1000 µg/mL), followed by stimulation for 0–48 h. A control group was used to compare the wound healing properties in the presence and absence of CLEPS. Photomicrographs of the wound closure (cell migration) were taken at 0–48 h of the same wounded areas using the inverted microscope (Zeiss, Jena, Germany). The % change of wound area in pixels was quantified manually for each image using ImageJ Software (v1.52a, National Institutes of Health, Bethesda, MD, USA).

2.10. Statistical Analysis

Bio-functional assays of the CLEPS in each platform were performed in triplicate. The results were expressed as the mean ± standard deviation. Statistical analyses were carried out using ANOVA, followed by Tukey HSD post-hoc test or Student’s t-test. These tests were performed using SPSS software (v25, International Business Machines, Armonk, NY, USA) and Microsoft Excel (v1905, Microsoft, USA). A p value of <0.05 was considered statistically significant.

3. Results and Discussion

3.1. Measurement of Antioxidant Activity

The antioxidant activity of the solutions was evaluated by the DPPH and ABTS assays. Given the fact that most natural antioxidants hold reactive hydrogens, which serve as reductants, both DPPH and ABTS assays are a useful measure of standard antioxidant profile. As shown in Figure 2, CLEPS solution (5 mg/mL) exhibited the ability to scavenge ~81% DPPH (a) and ~85% ABTS (b) free radicals (active oxygen) as equivalent to ascorbic acid (AA, 1 mg/mL).

3.2. Cell Viability Assay

As presented in Figure 3, no toxicity on the viability of NHDF (a) and B16 melanoma cells (b) was observed when CLEPS was tested at a wide range of concentration (0.05–7 mg/mL). Moreover, it was determined that the CLEPS treatment could induce fibroblast cell proliferation in a dose-dependent manner at 1–7 mg/mL. This finding was in good agreement with that of another study, which reported on the cell proliferation effect of a bioactive polysaccharide extract from Auricularia auricula-judae mushrooms [21].

3.3. Expression Level of Filaggrin

Filaggrins are an adhesive to hold keratin together, gradually flattening the shape of keratinocytes, increasing the strength of the skin barrier, and strengthening the cohesion between cells in the skin surface [22]. As presented in Figure 3c, when HaCaT cells were treated with CLEPS (30–300 μg/ml), the level of filaggrin expression at 300 µg/ml was significantly increased by 36% in contrast to the untreated group, confirming CLEPS could enhance or preserve the capability of skin barrier and moisturize through upregulation of filaggrin. To evaluate effective anti-dry skin function via filaggrin upregulation, plant extracts derived from Artemisia princeps [23], Rhodiola crenulate [24], or a mixture of Actinidia arguta and Perilla frutescens [25] were studied, while a fungal metabolite such as GFF [26] were investigated. In this regard, CLEPS would be a new filaggrin-enhancing ingredient based on a fungal metabolite if further developed.

3.4. Melanogenesis Inhibition Test of B16 Melanoma Cells

When CLEPS (0.5, 1.5 mg/mL) was added to the α-MSH-induced melanocytes, melanin synthesis was effectively inhibited by 43%, 54%, and 57%, respectively, in a concentration-dependent manner (Figure 3d). It has been confirmed that CLEPS can downregulate melanin synthesis more efficiently than 50 µg/ml of arbutin (41%). As an active compound extracted from the bearberry plant in Arctostaphylos, arbutin is a well-known melanin suppressor in cultured human melanocytes or B16 murine melanocytes [27]. Although it is therefore being widely used as a skin-lightening agent in the cosmetic market, many uncertainties remain, i.e., arbutin is a glycosylated hydroquinone that may cause cancer risks [28]. Considering arbutin is a recognized whitening single compound, it is very encouraging that CLEPS not only exhibited a skin-whitening effect by inhibiting the synthesis of melanin, but also showed superior whitening function over arbutin, even though it is an unidentified complex compound.

3.5. Anti-Inflammation Assay of NO, iNOS, COX2, and TNFα

When CLEPS 500 µg/mL was treated, the levels of inflammation-related factors, NO (a), iNOS (b), COX2 (c), and TNFα (d) were significantly reduced by ~75%, ~85%, 62%, and 55%, respectively (Figure 4). It was confirmed that CLEPS exerts an anti-inflammatory effect by regulating the inflammatory signaling pathway via suppressing the production of NO and the expression of inflammation-related genes. The potent inhibition of NO and TNF-α activity was comparable to those of commercially available edible mushrooms, such as Enoki, Shiitake, and Oyster, as the most potent anti-inflammatory species among mushrooms (IC₅₀ < 0.1 mg/mL) [29].

3.6. Synthesis of Collagen and Inhibition of Collagenase

Collagen is not only a key component supporting skin structure, but it can also directly control the wound microenvironment, serve as a scaffold for cell adhesion and function, or deliver biologically active ingredients to aid wound healing [1]. When damaged or deficient, the skin can wrinkle, deform, or cause skin disease. To confirm the anti-wrinkle efficacy of the CLEPS, synthesis of the collagen and inhibition of collagenase assays were performed as shown in Figure 5. Compared with the control groups, the groups treated with 10 ng/mL of TGF-β as a positive control showed a substantial increase in collagen synthesis by ~52%. The collagen synthesis was increased to 27.4%, 31.9%, and 65.4% in the groups treated with CLEPS at concentrations of 0.5, 1, and 5 mg/mL, accordingly in a concentration-dependent manner. PMA is a major ROS generating substance and has been routinely used as an endogenous inducer of superoxide production, which can increase MMP activity in dermal fibroblasts, resulting in extracellular matrix (ECM) protein degradation and premature skin aging [30]. In this work, the MMP-1 proteins were substantially increased after being treated with 50 nM of PMA, while it substantially dropped to 93.4% in the presence of CLEPS (5 mg/mL) in a concentration-dependent manner, indicating that CLEPS suppressed the collagenase activity by inhibiting PMA-induced oxidative stress to make NHDF cell death. Thus, it was confirmed that CLEPS could be effective in wrinkle improvement through collagen synthesis and collagenase reduction in skin ECM.

3.7. In Vitro Wound Healing Assay

ROS-mediated oxidative stress weakens the dermal structural and mechanical integrity of a tissue microenvironment that contributes to age-related skin disorders, such as delayed wound healing [31,32]. To investigate the effect of CLEPS on the wound recovery process, HaCaT cells were grown in a low serum medium (1%) (serum starvation) for 0–48 h at 37 °C. During wound healing assays, cells not only migrate with that gap, but they also multiply. To properly discriminate the migratory capacity of cells, it can be inhibited by treating the cells with the minimal nutrient conditions before creating gaps. As presented in Figure 6, the cells treated with CLEPS at 500 μg/ml exhibited accelerated cell migration up to ~60% or ~90% decrease of the wound area after 12 h or 24 h, correspondingly, as compared to control cells. The data revealed that treatment with the CLEPS could contribute to a skin wound healing in a day. Moreover, this result appears to be consistent with the MTT results described above, where CLEPS can aid cell activation in human dermal cells such as NHDF. Therefore, fungal polysaccharide can be a major cell healing effector, as demonstrated in the previous result that the polysaccharide extract of A. auricula-judae showed wound healing effect within 48 h through the skin cell proliferation mechanism [21].

Thus, CLEPS may contain bioactive ingredients in related to anti-aging, anti-oxidation, and anti-inflammatory properties. In the previous initial study, a submerged culture condition for the mycelium biomass and EPS production by C. lacerata were studied [33]. As a result of EPS analyses using HPLC, FT-IR, and NMR, it was found to be composed of polysaccharides, including mannose (83.36%), galactose (12.54%), and glucose (4.10%). Some flavonoids (e.g., dimethylchalcone) and tremulan sesquiterpenoids (e.g., triphonol) have been also isolated as potent bioactive components [34,35]. However, further research is needed to clarify these active compounds.

4. Conclusions

Taken together, our findings indicated that the CLEPS as a new skincare solution exerts a potential cosmeceutical effect on human skin cell aging through anti-oxidation, anti-inflammation, anti-breakdown of skin barrier, and wound healing. Especially, CLEPS not only significantly increased collagen and filaggrin synthesis, but also markedly inhibited the activity of collagenase, possibly indicating that CLEPS could prevent skin barrier damage or skin wrinkles. Although the exact compounds producing these effects are unknown, CLEPS as a novel natural anti-aging ingredient could be used as innovative functional cosmetics. Furthermore, the CLEPS manufacturing process is not an extraction process that mainly uses chemical organic solvents or conducts animal testing, but a bio-,eco-friendly, green microbial culture process, which can be well fit with the latest beauty trends in the “vegan” cosmetics market.